News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
David R. King Joins Diasome Pharmaceuticals as Chairman of the Board
November 24, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Diasome Pharmaceuticals, Inc., a clinical stage diabetes therapeutics company, announced today that David R. King has been appointed as the Company’s Chairman of the Board.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Layoffs
Genentech Lays Off 143 Employees in South San Francisco Reshuffle
June 11, 2025
·
1 min read
·
Dan Samorodnitsky
Deals
BMS Expands Radiopharma Presence With $1.35B Biobucks Deal for Philochem
June 11, 2025
·
2 min read
·
Tristan Manalac
Funding
SpliceBio Nabs $135 Million Series B To Advance Protein Splicing Medicines
June 11, 2025
·
2 min read
·
Dan Samorodnitsky
Layoffs
After Axing Diabetes Asset, Vertex Lays Off 140 Staff
June 11, 2025
·
2 min read
·
Tristan Manalac
